US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

60 degrees pharmaceuticals, Inc.

0.9734

-0.0067-0.68%

Post-market: 0.99530.0219+2.25%19:41 EST

Volume:159.70K

Turnover:160.41K

Market Cap:4.12M

PE:-0.12

High:1.04

Open:0.9804

Low:0.9600

Close:0.9801

52wk High:12.45

52wk Low:0.8500

Shares:4.23M

Float Shares:3.67M

Volume Ratio:4.21

T/O Rate:4.35%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.9044

EPS(LYR):-18.5454

ROE:-154.77%

ROA:-70.04%

PB:-0.80

PE(LYR):-0.05

Loading ...

Overview Company News Filings

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

BRIEF-60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient Enrollment

60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine

60 Degrees Pharmaceuticals Faces Financial Challenges Amid Growth Efforts

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP)

60 Degrees Pharm Coverage Assumed by HC Wainwright & Co. at Buy

60 Degrees Q3 EPS $(0.66) Beats $(1.21) Estimate, Sales $437.602K Beat $400.000K Estimate

60 Degrees Pharmaceuticals Q3 Operating Expenses USD 2.32 Million

THOMSON REUTERS

60 Degrees Pharmaceuticals Q3 Net Income USD -2.44 Million

THOMSON REUTERS

60 Degrees Pharmaceuticals Q3 EPS USD -0.66

THOMSON REUTERS

Press Release: 60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, First Horizon, 60 Degrees

BUZZ-60 Degrees jumps after first patient in tick-borne illness trial clears infection

60 Degrees Pharmaceuticals Inc - to Request Type B Meeting With FDA in Early 2026

THOMSON REUTERS

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

60 Degrees Pharmaceuticals Holds Annual Stockholders Meeting

60 Degrees Pharmaceuticals Inc held annual stockholders meeting

60 Degrees Pharmaceuticals unveils name of chronic babesiosis trial

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-Free Chronic Babesiosis Study

THOMSON REUTERS

60 Degrees Pharmaceuticals Inc. Enters New Sales Agreement with H.C. Wainwright & Co

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SXTP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SXTP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":0.9734,"timestamp":1764968400000,"preClose":0.9801,"halted":0,"volume":159700,"hourTrading":{"tag":"盘后","latestPrice":0.9953,"preClose":0.9734,"latestTime":"19:41 EST","volume":1277,"amount":1273.3001,"timestamp":1764981708957},"delay":0,"floatShares":3670200,"shares":4230448,"eps":-7.90436,"marketStatus":"Market Closed","change":-0.0067,"latestTime":"12-05 16:00:00 EST","open":0.9804,"high":1.04,"low":0.96,"amount":160406.36907,"amplitude":0.081624,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.90436,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":0.9801,"preHourTrading":{"tag":"盘前","latestPrice":1.02,"preClose":0.9801,"latestTime":"08:25 EST","volume":4994,"amount":5093.88,"timestamp":1764941144768},"postHourTrading":{"tag":"盘后","latestPrice":0.9953,"preClose":0.9734,"latestTime":"19:41 EST","volume":1277,"amount":1273.3001,"timestamp":1764981708957},"volumeRatio":4.205376126929019},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","floatShares":3670200,"roa":"-70.04%","roe":"-154.77%","lyrEps":-18.545406,"volumeRatio":4.205376126929019,"shares":4230448,"dividePrice":0,"high":1.04,"amplitude":0.081624,"preClose":0.9801,"low":0.96,"week52Low":0.85,"pbRate":"-0.80","psRate":"3.02","week52High":12.45,"institutionHeld":0,"latestPrice":0.9734,"eps":-7.90436,"divideRate":0,"volume":159700,"delay":0,"ttmEps":-7.90436,"open":0.9804,"prevYearClose":6.45,"prevWeekClose":1.0602,"prevMonthClose":1.0602,"prevQuarterClose":1.48,"fiveDayClose":1.0602,"twentyDayClose":1.3,"sixtyDayClose":1.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-24","symbol":"SXTP","defaultRemindTime":1740407400000,"type":"split","dateTimestamp":1740373200000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2024-08-12","symbol":"SXTP","defaultRemindTime":1723469400000,"type":"split","dateTimestamp":1723435200000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1763182800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SXTP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SXTP","date":"2025-12-05","current":-0.123147,"percent":0.650602,"low":-5.827686,"twenty":-1.314867,"median":-0.740528,"eighty":-0.391831,"high":-0.148542,"avg":-1.035344,"sd":1.021748,"marketCap":4146262},"quantilePoints":[{"date":"2023-07-14","current":-3.206044,"twenty":-3.575483,"median":-3.312205,"eighty":-3.248508,"marketCap":25229961},{"date":"2023-07-21","current":-2.066589,"twenty":-3.269741,"median":-2.519541,"eighty":-2.109053,"marketCap":16263021},{"date":"2023-07-28","current":-1.549942,"twenty":-3.005047,"median":-2.066589,"eighty":-1.612223,"marketCap":12197266},{"date":"2023-08-04","current":-1.436704,"twenty":-2.556343,"median":-1.68795,"eighty":-1.51314,"marketCap":11306141},{"date":"2023-08-11","current":-1.082836,"twenty":-2.270417,"median":-1.578251,"eighty":-1.364515,"marketCap":8521377},{"date":"2023-08-18","current":-1.132378,"twenty":-2.130285,"median":-1.514555,"eighty":-1.186166,"marketCap":8911244},{"date":"2023-08-25","current":-1.075759,"twenty":-1.995815,"median":-1.493323,"eighty":-1.119638,"marketCap":8465682},{"date":"2023-09-01","current":-0.896195,"twenty":-1.818881,"median":-1.298696,"eighty":-1.075759,"marketCap":8118769},{"date":"2023-09-08","current":-0.774624,"twenty":-1.702813,"median":-1.231461,"eighty":-0.96014,"marketCap":7017437},{"date":"2023-09-15","current":-0.729811,"twenty":-1.64761,"median":-1.146532,"eighty":-0.891125,"marketCap":6611469},{"date":"2023-09-22","current":-0.512148,"twenty":-1.583913,"median":-1.121762,"eighty":-0.799591,"marketCap":4639628},{"date":"2023-09-29","current":-0.473737,"twenty":-1.572589,"median":-1.082836,"eighty":-0.74506,"marketCap":4291655},{"date":"2023-10-06","current":-0.428924,"twenty":-1.54428,"median":-1.043911,"eighty":-0.582824,"marketCap":3885688},{"date":"2023-10-13","current":-0.449858,"twenty":-1.518801,"median":-0.952467,"eighty":-0.507026,"marketCap":4075333},{"date":"2023-10-20","current":-0.524952,"twenty":-1.507478,"median":-0.898787,"eighty":-0.48823,"marketCap":4755618},{"date":"2023-10-27","current":-0.423162,"twenty":-1.507478,"median":-0.893026,"eighty":-0.483288,"marketCap":3833492},{"date":"2023-11-03","current":-0.377709,"twenty":-1.498985,"median":-0.86425,"eighty":-0.474121,"marketCap":3421725},{"date":"2023-11-10","current":-0.384111,"twenty":-1.459352,"median":-0.781026,"eighty":-0.464774,"marketCap":3479721},{"date":"2023-11-17","current":-0.435326,"twenty":-1.364515,"median":-0.768158,"eighty":-0.451894,"marketCap":3943683},{"date":"2023-11-24","current":-0.957437,"twenty":-1.302234,"median":-0.768222,"eighty":-0.451215,"marketCap":3282536},{"date":"2023-12-01","current":-1.048783,"twenty":-1.272509,"median":-0.817837,"eighty":-0.455018,"marketCap":3595711},{"date":"2023-12-08","current":-1.126596,"twenty":-1.237122,"median":-0.883455,"eighty":-0.458974,"marketCap":3862490},{"date":"2023-12-15","current":-1.209483,"twenty":-1.239655,"median":-0.898787,"eighty":-0.463494,"marketCap":4146667},{"date":"2023-12-22","current":-1.860743,"twenty":-1.313345,"median":-0.952467,"eighty":-0.469896,"marketCap":6379488},{"date":"2023-12-29","current":-1.877659,"twenty":-1.436704,"median":-0.957437,"eighty":-0.473737,"marketCap":6437483},{"date":"2024-01-05","current":-1.843828,"twenty":-1.498985,"median":-0.99083,"eighty":-0.473737,"marketCap":6321493},{"date":"2024-01-12","current":-1.684903,"twenty":-1.535158,"median":-1.005049,"eighty":-0.473737,"marketCap":5776626},{"date":"2024-01-19","current":-1.239932,"twenty":-1.578554,"median":-1.044215,"eighty":-0.473993,"marketCap":4251059},{"date":"2024-01-26","current":-0.829046,"twenty":-1.566927,"median":-1.048783,"eighty":-0.474761,"marketCap":2842352},{"date":"2024-02-02","current":-0.925149,"twenty":-1.540086,"median":-1.013507,"eighty":-0.475465,"marketCap":3171838},{"date":"2024-02-09","current":-0.910618,"twenty":-1.523834,"median":-0.998035,"eighty":-0.47745,"marketCap":3122019},{"date":"2024-02-16","current":-1.032034,"twenty":-1.51597,"median":-0.998035,"eighty":-0.482239,"marketCap":3538288},{"date":"2024-02-23","current":-0.952597,"twenty":-1.507478,"median":-0.999534,"eighty":-0.485478,"marketCap":3265942},{"date":"2024-03-01","current":-0.872837,"twenty":-1.504647,"median":-0.997482,"eighty":-0.487014,"marketCap":2992488},{"date":"2024-03-08","current":-0.96067,"twenty":-1.485273,"median":-0.987859,"eighty":-0.492942,"marketCap":3293619},{"date":"2024-03-15","current":-0.79114,"twenty":-1.449798,"median":-0.959539,"eighty":-0.498115,"marketCap":2712392},{"date":"2024-03-22","current":-0.916107,"twenty":-1.420017,"median":-0.955017,"eighty":-0.500624,"marketCap":3140839},{"date":"2024-03-28","current":-0.855077,"twenty":-1.353268,"median":-0.952532,"eighty":-0.505746,"marketCap":2931598},{"date":"2024-04-05","current":-0.849647,"twenty":-1.338044,"median":-0.936451,"eighty":-0.512148,"marketCap":3199516},{"date":"2024-04-12","current":-0.816395,"twenty":-1.316389,"median":-0.933222,"eighty":-0.524952,"marketCap":3074302},{"date":"2024-04-19","current":-0.757247,"twenty":-1.308779,"median":-0.92967,"eighty":-0.530713,"marketCap":2851568},{"date":"2024-04-26","current":-0.717764,"twenty":-1.281002,"median":-0.922727,"eighty":-0.537755,"marketCap":2702887},{"date":"2024-05-03","current":-0.712848,"twenty":-1.27038,"median":-0.915462,"eighty":-0.550879,"marketCap":2684374},{"date":"2024-05-10","current":-0.706703,"twenty":-1.25977,"median":-0.903415,"eighty":-0.619133,"marketCap":2661232},{"date":"2024-05-17","current":-3.509711,"twenty":-1.27038,"median":-0.90138,"eighty":-0.641256,"marketCap":2580238},{"date":"2024-05-24","current":-4.594449,"twenty":-1.338044,"median":-0.91304,"eighty":-0.64525,"marketCap":3377706},{"date":"2024-05-31","current":-4.661966,"twenty":-1.461121,"median":-0.918206,"eighty":-0.666636,"marketCap":3427342},{"date":"2024-06-07","current":-5.728069,"twenty":-1.522366,"median":-0.927087,"eighty":-0.675178,"marketCap":4211110},{"date":"2024-06-14","current":-4.678752,"twenty":-1.578453,"median":-0.931607,"eighty":-0.675977,"marketCap":3439683},{"date":"2024-06-21","current":-4.565851,"twenty":-1.664999,"median":-0.933222,"eighty":-0.682122,"marketCap":3356681},{"date":"2024-06-28","current":-4.459591,"twenty":-1.683685,"median":-0.93467,"eighty":-0.688267,"marketCap":3278562},{"date":"2024-07-05","current":-3.848597,"twenty":-1.749099,"median":-0.942586,"eighty":-0.700189,"marketCap":2829377},{"date":"2024-07-12","current":-4.084361,"twenty":-1.843828,"median":-0.952597,"eighty":-0.706457,"marketCap":3002704},{"date":"2024-07-15","current":-4.07606,"twenty":-1.847211,"median":-0.952597,"eighty":-0.70658,"marketCap":2996601},{"date":"2024-08-02","current":-2.282925,"twenty":-1.860743,"median":-0.955017,"eighty":-0.706703,"marketCap":1678340},{"date":"2024-08-09","current":-1.534126,"twenty":-1.877659,"median":-0.959539,"eighty":-0.710605,"marketCap":1127845},{"date":"2024-08-16","current":-1.068072,"twenty":-1.877659,"median":-0.987859,"eighty":-0.712848,"marketCap":1678338},{"date":"2024-08-23","current":-2.160665,"twenty":-1.877659,"median":-0.997482,"eighty":-0.717764,"marketCap":3395207},{"date":"2024-08-30","current":-1.710527,"twenty":-1.890582,"median":-0.999534,"eighty":-0.729811,"marketCap":2687872},{"date":"2024-09-06","current":-1.620499,"twenty":-1.88984,"median":-1.0072,"eighty":-0.729811,"marketCap":2546405},{"date":"2024-09-13","current":-1.530471,"twenty":-1.880058,"median":-1.014951,"eighty":-0.730006,"marketCap":2404938},{"date":"2024-09-20","current":-1.521468,"twenty":-1.877659,"median":-1.04133,"eighty":-0.731038,"marketCap":2390791},{"date":"2024-09-27","current":-1.468799,"twenty":-1.869809,"median":-1.049471,"eighty":-0.737686,"marketCap":2308028},{"date":"2024-10-04","current":-1.255991,"twenty":-1.862164,"median":-1.066844,"eighty":-0.740259,"marketCap":1973628},{"date":"2024-10-11","current":-1.244142,"twenty":-1.847211,"median":-1.075002,"eighty":-0.740502,"marketCap":1955009},{"date":"2024-10-18","current":-1.232293,"twenty":-1.843828,"median":-1.079298,"eighty":-0.743697,"marketCap":1936390},{"date":"2024-10-25","current":-1.016642,"twenty":-1.840904,"median":-1.082836,"eighty":-0.754697,"marketCap":1597522},{"date":"2024-10-31","current":-0.975171,"twenty":-1.832216,"median":-1.075759,"eighty":-0.763051,"marketCap":1532355},{"date":"2024-11-08","current":-1.26784,"twenty":-1.806613,"median":-1.075381,"eighty":-0.767663,"marketCap":1992247},{"date":"2024-11-15","current":-1.125653,"twenty":-1.78406,"median":-1.082836,"eighty":-0.768196,"marketCap":1768818},{"date":"2024-11-22","current":-0.205615,"twenty":-1.766768,"median":-1.075381,"eighty":-0.742898,"marketCap":1627312},{"date":"2024-11-29","current":-0.307708,"twenty":-1.757765,"median":-1.071273,"eighty":-0.734485,"marketCap":2435312},{"date":"2024-12-06","current":-0.345446,"twenty":-1.750257,"median":-1.065617,"eighty":-0.722583,"marketCap":2733983},{"date":"2024-12-13","current":-0.47898,"twenty":-1.738613,"median":-1.055566,"eighty":-0.706334,"marketCap":3790817},{"date":"2024-12-20","current":-0.40931,"twenty":-1.727188,"median":-1.048783,"eighty":-0.67358,"marketCap":3239425},{"date":"2024-12-27","current":-0.38899,"twenty":-1.717281,"median":-1.039648,"eighty":-0.641313,"marketCap":3078603},{"date":"2025-01-03","current":-0.380281,"twenty":-1.712721,"median":-1.016642,"eighty":-0.550879,"marketCap":3009679},{"date":"2025-01-10","current":-0.316417,"twenty":-1.710966,"median":-1.012063,"eighty":-0.522391,"marketCap":2504236},{"date":"2025-01-17","current":-0.239606,"twenty":-1.690028,"median":-1.00281,"eighty":-0.496592,"marketCap":1896327},{"date":"2025-01-24","current":-0.255137,"twenty":-1.68399,"median":-0.998035,"eighty":-0.483288,"marketCap":2019241},{"date":"2025-01-31","current":-0.232233,"twenty":-1.673079,"median":-0.992315,"eighty":-0.474953,"marketCap":1837972},{"date":"2025-02-07","current":-0.153564,"twenty":-1.664392,"median":-0.980029,"eighty":-0.471176,"marketCap":1215358},{"date":"2025-02-14","current":-0.582606,"twenty":-1.637571,"median":-0.96067,"eighty":-0.473737,"marketCap":4610947},{"date":"2025-02-21","current":-0.439583,"twenty":-1.620499,"median":-0.957437,"eighty":-0.473737,"marketCap":3479015},{"date":"2025-02-28","current":-0.349879,"twenty":-1.606995,"median":-0.952597,"eighty":-0.455018,"marketCap":2769070},{"date":"2025-03-07","current":-0.295909,"twenty":-1.586175,"median":-0.942586,"eighty":-0.438837,"marketCap":2341926},{"date":"2025-03-14","current":-0.325686,"twenty":-1.5827,"median":-0.933946,"eighty":-0.428924,"marketCap":2577592},{"date":"2025-03-21","current":-0.36849,"twenty":-1.578554,"median":-0.931607,"eighty":-0.419612,"marketCap":2916361},{"date":"2025-03-28","current":-0.338713,"twenty":-1.572643,"median":-0.927312,"eighty":-0.40931,"marketCap":2680696},{"date":"2025-04-04","current":-0.34102,"twenty":-1.562151,"median":-0.925149,"eighty":-0.394645,"marketCap":2710119},{"date":"2025-04-11","current":-0.574544,"twenty":-1.556789,"median":-0.915785,"eighty":-0.39251,"marketCap":4565962},{"date":"2025-04-17","current":-0.587517,"twenty":-1.553338,"median":-0.908035,"eighty":-0.394595,"marketCap":4669064},{"date":"2025-04-25","current":-0.543037,"twenty":-1.552371,"median":-0.898993,"eighty":-0.395957,"marketCap":4315570},{"date":"2025-05-02","current":-0.459635,"twenty":-1.549767,"median":-0.893026,"eighty":-0.401762,"marketCap":3652769},{"date":"2025-05-09","current":-0.418861,"twenty":-1.547598,"median":-0.874888,"eighty":-0.406988,"marketCap":3328733},{"date":"2025-05-16","current":-0.398474,"twenty":-1.541724,"median":-0.870254,"eighty":-0.406988,"marketCap":3166715},{"date":"2025-05-23","current":-0.323906,"twenty":-1.541274,"median":-0.86425,"eighty":-0.394595,"marketCap":3321369},{"date":"2025-05-30","current":-0.382079,"twenty":-1.539474,"median":-0.855077,"eighty":-0.384111,"marketCap":3917890},{"date":"2025-06-06","current":-0.425171,"twenty":-1.534126,"median":-0.848946,"eighty":-0.384111,"marketCap":4359757},{"date":"2025-06-13","current":-0.327497,"twenty":-1.530471,"median":-0.844971,"eighty":-0.384111,"marketCap":3358191},{"date":"2025-06-20","current":-0.31026,"twenty":-1.530471,"median":-0.840362,"eighty":-0.383346,"marketCap":3181444},{"date":"2025-06-27","current":-0.350479,"twenty":-1.530471,"median":-0.828469,"eighty":-0.382076,"marketCap":3593854},{"date":"2025-07-03","current":-0.34186,"twenty":-1.52737,"median":-0.817007,"eighty":-0.376415,"marketCap":3505480},{"date":"2025-07-11","current":-0.374897,"twenty":-1.5231,"median":-0.815166,"eighty":-0.372679,"marketCap":3844245},{"date":"2025-07-18","current":-0.475084,"twenty":-1.521534,"median":-0.809921,"eighty":-0.369678,"marketCap":4871569},{"date":"2025-07-25","current":-0.421598,"twenty":-1.513366,"median":-0.799667,"eighty":-0.370493,"marketCap":4323114},{"date":"2025-08-01","current":-0.421598,"twenty":-1.507672,"median":-0.795011,"eighty":-0.372679,"marketCap":4323114},{"date":"2025-08-08","current":-0.415305,"twenty":-1.507478,"median":-0.778869,"eighty":-0.374314,"marketCap":4258590},{"date":"2025-08-15","current":-0.688009,"twenty":-1.505883,"median":-0.772764,"eighty":-0.374475,"marketCap":5376854},{"date":"2025-08-22","current":-0.682757,"twenty":-1.499955,"median":-0.768222,"eighty":-0.374728,"marketCap":5335809},{"date":"2025-08-29","current":-0.682757,"twenty":-1.494678,"median":-0.762084,"eighty":-0.376584,"marketCap":5335809},{"date":"2025-09-05","current":-0.777292,"twenty":-1.488443,"median":-0.762018,"eighty":-0.378738,"marketCap":6074614},{"date":"2025-09-12","current":-0.74578,"twenty":-1.476193,"median":-0.74578,"eighty":-0.380993,"marketCap":5828345},{"date":"2025-09-19","current":-0.766788,"twenty":-1.46646,"median":-0.748406,"eighty":-0.382069,"marketCap":5992524},{"date":"2025-09-26","current":-0.730024,"twenty":-1.462951,"median":-0.74578,"eighty":-0.382521,"marketCap":5705211},{"date":"2025-10-03","current":-0.751032,"twenty":-1.458999,"median":-0.74578,"eighty":-0.383184,"marketCap":5869390},{"date":"2025-10-10","current":-0.858698,"twenty":-1.446524,"median":-0.751032,"eighty":-0.383196,"marketCap":6710806},{"date":"2025-10-17","current":-0.787796,"twenty":-1.429197,"median":-0.756284,"eighty":-0.383281,"marketCap":6156703},{"date":"2025-10-24","current":-0.761536,"twenty":-1.402924,"median":-0.761536,"eighty":-0.383672,"marketCap":5951480},{"date":"2025-10-31","current":-0.724772,"twenty":-1.373296,"median":-0.759391,"eighty":-0.384111,"marketCap":5664167},{"date":"2025-11-07","current":-0.682757,"twenty":-1.358886,"median":-0.756284,"eighty":-0.384111,"marketCap":5335809},{"date":"2025-11-14","current":-0.614481,"twenty":-1.347178,"median":-0.748406,"eighty":-0.384111,"marketCap":4802228},{"date":"2025-11-21","current":-0.535994,"twenty":-1.331765,"median":-0.74578,"eighty":-0.386063,"marketCap":4272752},{"date":"2025-11-28","current":-0.562635,"twenty":-1.321155,"median":-0.74578,"eighty":-0.389423,"marketCap":4485120},{"date":"2025-12-05","current":-0.520127,"twenty":-1.314867,"median":-0.740528,"eighty":-0.391831,"marketCap":4146262}],"updateTime":1765128718077},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586093786","title":"60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2586093786","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586093786?lang=en_us&edition=fundamental","pubTime":"2025-11-28 19:09","pubTimestamp":1764328140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SXTP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 28, 2025 06:09 ET (11:09 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2585145552","title":"BRIEF-60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2585145552","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585145552?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:26","pubTimestamp":1763731611,"startTime":"0","endTime":"0","summary":"BRIEF-60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient EnrollmentNov 21 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACEUTICALS ANNOUNCES CLINICAL SITE NOW ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nTUA9KLPY7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTPW","SXTP"],"gpt_icon":0},{"id":"2585143190","title":"60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2585143190","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585143190?lang=en_us&edition=fundamental","pubTime":"2025-11-21 21:01","pubTimestamp":1763730060,"startTime":"0","endTime":"0","summary":"90-day trial will measure change in general fatigue in patients with chronic babesiosis followingtafenoquine treatmentStudy will run approximately 12 months and enroll up to 100 patientsInternal estim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/21/3192770/0/en/60-Degrees-Pharmaceuticals-Announces-Clinical-Site-Now-Open-for-Patient-Enrollment-for-the-B-FREE-Chronic-Babesiosis-Study-at-Mount-Sinai-Icahn-School-of-Medicine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2584600663","title":"60 Degrees Pharmaceuticals Faces Financial Challenges Amid Growth Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2584600663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584600663?lang=en_us&edition=fundamental","pubTime":"2025-11-18 12:05","pubTimestamp":1763438731,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) has released its Q3 earnings. Here is a breakdown of the information 60 Degrees Pharmaceuticals, Inc. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-faces-financial-challenges-amid-growth-efforts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-faces-financial-challenges-amid-growth-efforts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2584617074","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584617074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584617074?lang=en_us&edition=fundamental","pubTime":"2025-11-17 15:30","pubTimestamp":1763364624,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Fate Therapeutics (FATE – Research Report), ALX On...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-fate-therapeutics-fate-alx-oncology-holdings-alxo-and-60-degrees-pharmaceuticals-inc-sxtp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-fate-therapeutics-fate-alx-oncology-holdings-alxo-and-60-degrees-pharmaceuticals-inc-sxtp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FATE","BK4080","ALXO","ALX","BK4139","BK4581","HCSG","LABU","LU0029874061.USD","LU0128526141.USD","XBI","BK4588","BK4585","BK4007","BK4231","XLV","SXTP","BK4137"],"gpt_icon":0},{"id":"2583450648","title":"60 Degrees Pharm Coverage Assumed by HC Wainwright & Co. at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2583450648","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583450648?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:58","pubTimestamp":1763125080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SXTP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2025 07:58 ET (12:58 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2583951538","title":"60 Degrees Q3 EPS $(0.66) Beats $(1.21) Estimate, Sales $437.602K Beat $400.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583951538","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583951538?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:54","pubTimestamp":1763060065,"startTime":"0","endTime":"0","summary":"60 Degrees (NASDAQ:SXTP) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(1.21) by 45.45 percent. This is a 85.81 percent increase over losses of $(4.65) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48845438/60-degrees-q3-eps-0-66-beats-1-21-estimate-sales-437-602k-beat-400-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2583515817","title":"60 Degrees Pharmaceuticals Q3 Operating Expenses USD 2.32 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583515817","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583515817?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:51","pubTimestamp":1763059860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX40A973:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2583515812","title":"60 Degrees Pharmaceuticals Q3 Net Income USD -2.44 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583515812","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583515812?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:51","pubTimestamp":1763059860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX40A973:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2583158105","title":"60 Degrees Pharmaceuticals Q3 EPS USD -0.66","url":"https://stock-news.laohu8.com/highlight/detail?id=2583158105","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583158105?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:51","pubTimestamp":1763059860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLX40A973:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2583158165","title":"Press Release: 60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583158165","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583158165?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:51","pubTimestamp":1763059860,"startTime":"0","endTime":"0","summary":"-- Q3 2025 net product revenue increased 223% year-over-year to $438. -- Gross profit/ decreased from $24 thousand to $ thousand. WASHINGTON, Nov. 13, 2025  -- 60 Degrees Pharmaceuticals, Inc.  , a pharmaceutical company focused on developing new medicines for vector-borne disease, reported today its financial results for the third fiscal quarter of the 2025 year, ended September 30, 2025.-- ARAKODA pharmacy deliveries increased by 14% from 1,319 boxes (Q3. -- The Company posted a gross loss of approximately $100 thousand in the. third quarter of 2025, compared to an approximate gross profit of $24. thousand in the third quarter of 2024, due to a one-time inventory. write-off associated with newly produced validation lots which will no. longer be accepted by supply chain partners after the end of Q1 2026 due. to limited remaining shelf-life. Additional lots with four-year. shelf-life are currently in production and expected to fully enter the. -- Operating expenses were approximately $","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4022","SXTP","BK4007"],"gpt_icon":0},{"id":"2575802937","title":"BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, First Horizon, 60 Degrees","url":"https://stock-news.laohu8.com/highlight/detail?id=2575802937","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575802937?lang=en_us&edition=fundamental","pubTime":"2025-10-15 21:21","pubTimestamp":1760534473,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, First Horizon, 60 DegreesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nL6N3VW0KB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVD3.UK","3NVD.UK","SG9999018857.SGD","LU2322448791.USD","LU2048586759.USD","NVD","BK4587","LU1988902786.USD","IAT","ABT","DPST","IE00BN8TJ469.HKD","IE00B5949003.HKD","BTSG","XLF","NVDU","LU0082616367.USD","SG9999014906.USD","2NVD.UK","KRX","SXTP","BK4585","BK4504","BK4588","EYPT","ASPI","SOC","BAC","LU2272731782.SGD","NVDS","SNVD.UK","NVIW.SI","NVDA","NVD2.UK","LU1923622614.USD","EBAY","KRE","NVDD","NVDS.UK","KBE","NVDX","NEE","LU2272731600.USD","NVDY","LU0868494708.USD","IE0002270589.USD","PZZA","VFH","DLTR","FHN","LU2756315664.SGD","GE","KBWB","RUN","LU0175139822.USD","LU1323610961.USD"],"gpt_icon":1},{"id":"2575841367","title":"BUZZ-60 Degrees jumps after first patient in tick-borne illness trial clears infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2575841367","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575841367?lang=en_us&edition=fundamental","pubTime":"2025-10-15 20:18","pubTimestamp":1760530729,"startTime":"0","endTime":"0","summary":"BUZZ-60 Degrees jumps after first patient in tick-borne illness trial clears infection** Specialty pharma firm 60 Degrees Pharmaceuticals' SXTP.O rise 27% to $2.28 in premarket trading** Co says first patient in babesiosis trial tested negative for infection after completing treatment** SXTP says babesiosis is a tick-borne illness; cases rising in U.S. Northeast, especially among elderly and immunosuppressed** Trial tests malaria drug tafenoquine with standard meds in patients who failed conventional treatment** Co says patient cleared infection by two sensitive lab tests, including an FDA-approved blood screening assay** Tafenoquine not yet approved for babesiosis; currently used for malaria prevention** SXTP says breakthrough therapy application for tafenoquine in babesiosis submitted to FDA on October 3** A breakthrough therapy tag is meant to speed up development and review of drugs to treat a serious condition or unmet medical need** Up to last close, stock down 72% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nL3N3VW0V4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2575786636","title":"60 Degrees Pharmaceuticals Inc - to Request Type B Meeting With FDA in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2575786636","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575786636?lang=en_us&edition=fundamental","pubTime":"2025-10-15 19:14","pubTimestamp":1760526840,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nTUAW4BXQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"2575786148","title":"60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2575786148","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575786148?lang=en_us&edition=fundamental","pubTime":"2025-10-15 19:14","pubTimestamp":1760526840,"startTime":"0","endTime":"0","summary":"Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA)Resu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/15/3166954/0/en/60-Degrees-Pharmaceuticals-Announces-No-Detection-of-Babesia-Infection-in-First-Patient-Following-Treatment-with-Tafenoquine-in-Relapsing-Babesiosis-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4139","ALT","BK4007","SXTP","LU1878469433.USD"],"gpt_icon":0},{"id":"2574100179","title":"60 Degrees Pharmaceuticals Holds Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2574100179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574100179?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:50","pubTimestamp":1760129453,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) has provided an update. On October 8, 2025, 60 Degrees Pharmaceuticals, Inc. held its virtual 2025 Ann...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-holds-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-holds-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2574107822","title":"60 Degrees Pharmaceuticals Inc held annual stockholders meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107822","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574107822?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:16","pubTimestamp":1760127369,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc. held its annual stockholders meeting on October 8, 2025. At the meeting, shareholders voted to elect five directors: Geoffrey Dow, Charles Allen, Cheryl Xu, Stephen Toovey, and Paul Field. All five nominees were elected.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL76lPlS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2574159112","title":"60 Degrees Pharmaceuticals unveils name of chronic babesiosis trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2574159112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574159112?lang=en_us&edition=fundamental","pubTime":"2025-10-09 19:11","pubTimestamp":1760008287,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced the name of its chronic babesiosis trial is the B-FREE Chronic Babesiosis Study. The B-FREE study, the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-unveils-name-of-chronic-babesiosis-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-unveils-name-of-chronic-babesiosis-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2574156230","title":"60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-Free Chronic Babesiosis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2574156230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574156230?lang=en_us&edition=fundamental","pubTime":"2025-10-09 19:04","pubTimestamp":1760007840,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251009:nTUA9JBKBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007","SXTPW"],"gpt_icon":0},{"id":"2565593678","title":"60 Degrees Pharmaceuticals Inc. Enters New Sales Agreement with H.C. Wainwright & Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2565593678","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565593678?lang=en_us&edition=fundamental","pubTime":"2025-09-06 04:21","pubTimestamp":1757103684,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc. has entered into a new At-The-Market Sales Agreement with H.C. Wainwright & Co., LLC as of September 3, 2025. This agreement allows the company to offer and sell shares of its common stock, with a total potential gross sales value of up to $1,397,533, through Wainwright acting as a sales agent or principal. The move follows the termination of a previous similar agreement with Wallachbeth Capital LLC, effective the same day. The sales under the new agreement will be conducted pursuant to the company's shelf registration statement filed with the SEC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDL8sbzLy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":36,"code":"91000000","status":"200"}]}}